Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 29, 2023
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
Tue, November 28, 2023
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
Akash Tewari Maintained (SLRN) at Strong Buy with Decreased Target to $12 on, Nov 28th, 2023
Akash Tewari of Jefferies, Maintained "Acelyrin, Inc." (SLRN) at Strong Buy with Decreased Target from $15 to $12 on, Nov 28th, 2023.
Akash has made no other calls on SLRN in the last 4 months.
There is 1 other peer that has a rating on SLRN. Out of the 1 peers that are also analyzing SLRN, all agrees with Akash's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vikram Purohit of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $19 on, Wednesday, September 13th, 2023
